Literature DB >> 7687263

Analysis of ODC and c-myc gene expression in hepatocellular carcinoma by in situ hybridization and immunohistochemistry.

F Y Gan1, M S Gesell, M Alousi, G D Luk.   

Abstract

We quantitated mRNA and protein for ornithine decarboxylase (ODC) and c-myc in formalin-fixed liver sections from 25 specimens of hepatocellular carcinoma (HCC) and seven normal livers by a non-radiolabeled in situ hybridization technique and immunohistochemistry. This non-radioactive in situ hybridization technique was highly specific, with virtually no background, and permitted quantitative analysis based on optical density. Reaction products were quantitated with computer-assisted microdensitometry. Samples were classified as normal, adjacent uninvolved, cirrhosis, well-differentiated HCC, and poorly-differentiated HCC. There was a progressive increase in all four parameters measured, ODC mRNA and protein, and c-myc mRNA and protein, from normal, to adjacent uninvolved liver, to cirrhosis, to well-differentiated HCC, to poorly-differentiated HCC. The sole exception was that ODC mRNA was lowest in cirrhosis. The patterns of ODC and c-myc gene expression are similar in HCC. The quantitative detection of ODC mRNA, c-myc mRNA, and their protein products in hepatocellular carcinoma and cirrhosis by in situ hybridization and immunohistochemical techniques may have a potential role in the study of hepatocarcinogenesis and in the diagnosis of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687263     DOI: 10.1177/41.8.7687263

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  11 in total

1.  Cafeteria diet-induced obese rats have an increased somatostatin protein content and gene expression in the periventricular nucleus.

Authors:  X Zhou; J De Schepper; A Vergeylen; O Luis; M Delhase; E L Hooghe-Peters
Journal:  J Endocrinol Invest       Date:  1997-05       Impact factor: 4.256

2.  The effects of varying key steps in the non-radioactive in situ hybridization protocol: a quantitative study.

Authors:  Y Guiot; J Rahier
Journal:  Histochem J       Date:  1995-01

3.  Expression of c-myc promoter binding protein (MBP-1), a novel eukaryotic repressor gene, in cirrhosis and human hepatocellular carcinoma.

Authors:  X Fan; H Solomon; K Schwarz; M C Kew; R B Ray; A M Di Bisceglie
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

4.  Xmrk, kras and myc transgenic zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma.

Authors:  Weiling Zheng; Zhen Li; Anh Tuan Nguyen; Caixia Li; Alexander Emelyanov; Zhiyuan Gong
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

Review 5.  Xmrks the Spot: Fish Models for Investigating Epidermal Growth Factor Receptor Signaling in Cancer Research.

Authors:  Jerry D Monroe; Faiza Basheer; Yann Gibert
Journal:  Cells       Date:  2021-05-07       Impact factor: 6.600

6.  A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors.

Authors:  Zhen Li; Weiling Zheng; Zhengyuan Wang; Zhiqiang Zeng; Huiqing Zhan; Caixia Li; Li Zhou; Chuan Yan; Jan M Spitsbergen; Zhiyuan Gong
Journal:  Dis Model Mech       Date:  2012-10-04       Impact factor: 5.758

7.  Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma.

Authors:  C G Wu; N A Habib; R R Mitry; P H Reitsma; S J van Deventer; R A Chamuleau
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer.

Authors:  Lionel Lim; Asha Balakrishnan; Noelle Huskey; Kirk D Jones; Mona Jodari; Raymond Ng; Guisheng Song; Jesse Riordan; Brittany Anderton; Siu-Tim Cheung; Holger Willenbring; Adam Dupuy; Xin Chen; David Brown; Aaron N Chang; Andrei Goga
Journal:  Hepatology       Date:  2013-11-22       Impact factor: 17.425

9.  Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.

Authors:  Lin Li; Qingsong Lei; Shujun Zhang; Lingna Kong; Bo Qin
Journal:  Oncol Rep       Date:  2017-09-07       Impact factor: 3.906

Review 10.  The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells.

Authors:  Andrea Antonosante; Michele d'Angelo; Vanessa Castelli; Mariano Catanesi; Dalila Iannotta; Antonio Giordano; Rodolfo Ippoliti; Elisabetta Benedetti; Annamaria Cimini
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.